About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness

MELBOURNE, Australia, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies (GTG) is proud to provide details of a series of recent transformative initiatives. Our commitment to advancing early detection of serious diseases through a revolutionary non-invasive saliva test has been recently showcased on several national Australian media channels. These segments highlight geneType's potential to shape the future of proactive health management.

Precision Medicine Takes Flight at Gold Coast Private Hospital (Ch 9 Media link to Video)

On Australian free to air television, Channel 9 News recently featured geneType's pioneering Precision & Preventive Medicine Clinic, marking a milestone in healthcare. Situated at Gold Coast Private Hospital, in Queensland, this clinic is the first of its kind in Australia, representing a fusion of cutting-edge technology and healthcare excellence. The clinic's establishment marks a significant leap forward in the integration of precision medicine into everyday healthcare practices.

To kickstart this revolutionary journey, geneType is initiating a 50-patient pilot study at Gold Coast Private Hospital. This partnership will establish a seamless workflow and patient reporting system, utilizing geneType's multi-risk test combined with Pharmacogenomics (PGx) tests. The result is a comprehensive wellness profile tailored to the unique needs of Gold Coast Private Hospital patients, setting a new standard in personalized healthcare.

The entire suite of diseases will be available to pilot participants including cancers such as breast, ovarian, colorectal, pancreatic, prostate, and melanoma and cardiovascular diseases such and coronary artery disease and atrial fibrillation and Type 2 diabetes.

Shining a Spotlight on Melanoma Detection (Ch 7 Media link to Video)

To highlight the importance of early detection, and therefore saving lives, geneType's world-first risk assessment test for Melanoma was recently featured on Channel 7's The Morning Show, a channel available on Australian free to air television, geneType ambassador, Deborah Hutton (Australian personality), shared her personal battle with melanoma, emphasizing the critical role of screening in the fight against this deadly disease.

University of Melbourne Partnership

GTG’s commitment to innovation continues with a groundbreaking partnership with the University of Melbourne. Genetic Technologies Limited has been named commercial partner for a $2.4 million Medical Research Future Fund (MRFF) grant funded trial, named CASSOWARY (CAncer genomic riSk ScOres in primARY Care). This multi-site study, led by Professor Jon Emery, aims to assess the viability of using geneType to evaluate genetic vulnerability to breast, colorectal, prostate, and melanoma cancers. As the sole commercial partner, GTG has positioned geneType at the forefront of transforming DNA testing into a cost-effective, efficient tool for personalized cancer risk management.

Professor Jon Emery notes, "DNA testing is pivotal in the prevention and early detection of cancer, allowing doctors to offer personalized risk management strategies."

GTG remains committed to pushing the boundaries of genomics, transforming the landscape of early disease detection, and empowering individuals to take control of their health journey.

Enquiries

Investor Relations
Adrian Mulcahy
Automic Markets
M: +61 438 630 411
E: adrian.mulcahy@automicgroup.com.au

About Genetic Technologies Limited

Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) is a diversified molecular diagnostics company. A global leader in genomics-based tests in health, wellness and serious disease through its geneType and EasyDNA brands. GTG offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The company has a proprietary risk stratification platform that has been developed over the past decade and integrates clinical and genetic risk to deliver actionable outcomes to physicians and individuals. Leading the world in risk prediction in oncology, cardiovascular and metabolic diseases, Genetic Technologies continues to develop risk assessment products. For more information, please visit www.genetype.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.